Skip to main content
Greenwich Biosciences Logo

Main navigation

  • Our Company
    • About Us
    • Our Leadership
    • Medical Affairs
  • Research
    • EPIDIOLEX® (cannabidiol)
    • Pipeline
  • Patients
  • News
    • Spotlight Articles
    • Media Library
  • Careers
  • Contact
  • United States
    • United States
    • Europe
    • Global Corporate

Site Map

Home

  • Our Company

    • About us
    • Our Leadership
    • Medical Affairs

  • Research

    • Epidiolex
    • Pipeline

  • News

    • Spotlight Articles
    • Press Releases
    • Media Library

  • Patients

  • Careers

  • Contact

    • Legal

    • Unsubscribe

  • LinkedIn
  • Twitter

Follow Us

Keep up with the latest news and updates about Greenwich Biosciences through social media.

Footer

  • Home
  • Our Company
  • Research
  • Patients
  • News
  • Careers
  • Contact
  • LinkedIn
  • Twitter

This website is sponsored by Greenwich Biosciences, Inc.

This site is not intended to provide medical advice or to suggest that any product mentioned is safe or efficacious for any disease or condition

second footer

  • Site Map
  • Privacy Policy
  • Terms of Use
  • Unsubscribe

©2020 Greenwich Biosciences, Inc. All rights reserved.
GBS-02157-0220

You are leaving the website of Greenwich Biosciences, Inc., the US subsidiary of GW Pharmaceuticals plc. This link will take you to a website to which our Privacy Policy does not apply.

Proceed to Website >

Stay on greenwichbiosciences.com >

Medical Inquiry Form

For questions about scientific and clinical information regarding Greenwich Biosciences products, complete the form below.

If you would like to contact Medical Information by phone, call (833) 424-6724

Request Type
PREFERRED CONTACT METHOD
Address Fields
By clicking Send Request, I confirm that this is an unsolicited request and consent to receive communications from Greenwich Biosciences, Inc.

Status message

Sorry...This form is closed to new submissions.

COVID-19 UPDATE

We are closely monitoring our supply chain of EPIDIOLEX® (cannabidiol) and, at this time, do not foresee any supply interruptions in the United States.

At Greenwich Biosciences, our main concern is the well-being of our patients, healthcare partners, and employees. Our hearts and thoughts go out to the people who have been affected. We are monitoring the COVID-19 situation and have taken steps to ensure that access and assistance for patients remain consistent.